Literature DB >> 10961873

Interleukin-3 supports expansion of long-term multilineage repopulating activity after multiple stem cell divisions in vitro.

D Bryder1, S E Jacobsen.   

Abstract

Although long-term repopulating hematopoietic stem cells (HSC) can self-renew and expand extensively in vivo, most efforts at expanding HSC in vitro have proved unsuccessful and have frequently resulted in compromised rather than improved HSC grafts. This has triggered the search for the optimal combination of cytokines for HSC expansion. Through such studies, c-kit ligand (KL), flt3 ligand (FL), thrombopoietin, and IL-11 have emerged as likely positive regulators of HSC self-renewal. In contrast, numerous studies have implicated a unique and potent negative regulatory role of IL-3, suggesting perhaps distinct regulation of HSC fate by different cytokines. However, the interpretations of these findings are complicated by the fact that different cytokines might target distinct subpopulations within the HSC compartment and by the lack of evidence for HSC undergoing self-renewal. Here, in the presence of KL+FL+megakaryocyte growth and development factor (MGDF), which recruits virtually all Lin(-)Sca-1(+)kit(+) bone marrow cells into proliferation and promotes their self-renewal under serum-free conditions, IL-3 and IL-11 revealed an indistinguishable ability to further enhance proliferation. Surprisingly, and similar to IL-11, IL-3 supported KL+FL+MGDF-induced expansion of multilineage, long-term reconstituting activity in primary and secondary recipients. Furthermore, high-resolution cell division tracking demonstrated that all HSC underwent a minimum of 5 cell divisions, suggesting that long-term repopulating HSC are not compromised by IL-3 stimulation after multiple cell divisions. In striking contrast, the ex vivo expansion of murine HSC in fetal calf serum-containing medium resulted in extensive loss of reconstituting activity, an effect further facilitated by the presence of IL-3. (Blood. 2000;96:1748-1755)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10961873

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

1.  In vitro culture during retroviral transduction improves thymic repopulation and output after total body irradiation and autologous peripheral blood progenitor cell transplantation in rhesus macaques.

Authors:  Karin Loré; Ruth Seggewiss; F Javier Guenaga; Stefania Pittaluga; Robert E Donahue; Allen Krouse; Mark E Metzger; Richard A Koup; Cavan Reilly; Daniel C Douek; Cynthia E Dunbar
Journal:  Stem Cells       Date:  2006-02-23       Impact factor: 6.277

2.  Bone marrow-on-a-chip replicates hematopoietic niche physiology in vitro.

Authors:  Yu-suke Torisawa; Catherine S Spina; Tadanori Mammoto; Akiko Mammoto; James C Weaver; Tracy Tat; James J Collins; Donald E Ingber
Journal:  Nat Methods       Date:  2014-05-04       Impact factor: 28.547

Review 3.  Hematopoietic stem cells: transcriptional regulation, ex vivo expansion and clinical application.

Authors:  R Aggarwal; J Lu; V J Pompili; H Das
Journal:  Curr Mol Med       Date:  2012-01       Impact factor: 2.222

4.  Cord blood-derived hematopoietic stem/progenitor cells: current challenges in engraftment, infection, and ex vivo expansion.

Authors:  Katsuhiro Kita; Jong O Lee; Celeste C Finnerty; David N Herndon
Journal:  Stem Cells Int       Date:  2011-04-27       Impact factor: 5.443

5.  Near-maximal expansions of hematopoietic stem cells in culture using NUP98-HOX fusions.

Authors:  Hideaki Ohta; Sanja Sekulovic; Silvia Bakovic; Connie J Eaves; Nicolas Pineault; Maura Gasparetto; Clayton Smith; Guy Sauvageau; R Keith Humphries
Journal:  Exp Hematol       Date:  2007-05       Impact factor: 3.084

6.  Expansion of human SCID-repopulating cells under hypoxic conditions.

Authors:  Guénahel H Danet; Yi Pan; Jennifer L Luongo; Dominique A Bonnet; M Celeste Simon
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

7.  Expansion on stromal cells preserves the undifferentiated state of human hematopoietic stem cells despite compromised reconstitution ability.

Authors:  Mattias Magnusson; Maria I Sierra; Rajkumar Sasidharan; Sacha L Prashad; Melissa Romero; Pamela Saarikoski; Ben Van Handel; Andy Huang; Xinmin Li; Hanna K A Mikkola
Journal:  PLoS One       Date:  2013-01-16       Impact factor: 3.240

8.  Ex vivo development, expansion and in vivo analysis of a novel lineage of dendritic cells from hematopoietic stem cells.

Authors:  Shuhong Han; Yichen Wang; Bei Wang; Ekta Patel; Starlyn Okada; Li-Jun Yang; Jan S Moreb; Lung-Ji Chang
Journal:  J Immune Based Ther Vaccines       Date:  2010-11-24

Review 9.  Increasing hematopoietic stem cell yield to develop mice with human immune systems.

Authors:  Juan-Carlos Biancotti; Terrence Town
Journal:  Biomed Res Int       Date:  2013-02-14       Impact factor: 3.411

10.  A novel assay to trace proliferation history in vivo reveals that enhanced divisional kinetics accompany loss of hematopoietic stem cell self-renewal.

Authors:  Jens M Nygren; David Bryder
Journal:  PLoS One       Date:  2008-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.